Aryl extensions of thienopyrimidinones as fibroblast growth factor receptor 1 kinase inhibitors
Keywords: FGFR1 kinase inhibitors; Structure-based inhibitor design; Thienopyrimidinones; ATP-competitive small molecule inhibitors;